PL1613589T3 - Nowy difenyloazetydynon o polepszonych właściwościach fizjologicznych, sposób jego wytwarzania, środki lecznicze zawierające ten związek i jego zastosowanie - Google Patents

Nowy difenyloazetydynon o polepszonych właściwościach fizjologicznych, sposób jego wytwarzania, środki lecznicze zawierające ten związek i jego zastosowanie

Info

Publication number
PL1613589T3
PL1613589T3 PL04720854T PL04720854T PL1613589T3 PL 1613589 T3 PL1613589 T3 PL 1613589T3 PL 04720854 T PL04720854 T PL 04720854T PL 04720854 T PL04720854 T PL 04720854T PL 1613589 T3 PL1613589 T3 PL 1613589T3
Authority
PL
Poland
Prior art keywords
compound
production method
physiological characteristics
corresponding production
medicaments containing
Prior art date
Application number
PL04720854T
Other languages
English (en)
Inventor
Gerhard Jaehne
Wendelin Frick
Andreas Lindenschmidt
Stefanie Flohr
Hubert Heuer
Hans-Ludwig Schaefer
Werner Kramer
Eric Galia
Heiner Glombik
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of PL1613589T3 publication Critical patent/PL1613589T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL04720854T 2003-04-01 2004-03-16 Nowy difenyloazetydynon o polepszonych właściwościach fizjologicznych, sposób jego wytwarzania, środki lecznicze zawierające ten związek i jego zastosowanie PL1613589T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10314610A DE10314610A1 (de) 2003-04-01 2003-04-01 Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
EP04720854A EP1613589B1 (de) 2003-04-01 2004-03-16 Neues diphenylazetidinon mit verbesserten physiologischen eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung
PCT/EP2004/002690 WO2004087655A1 (de) 2003-04-01 2004-03-16 Neues diphenylazetidinon mit verbesserten physiologischen eigenschaften, verfahren zu dessen herstellung, diese verbindungen enthaltende arzneimittel und dessen verwendung

Publications (1)

Publication Number Publication Date
PL1613589T3 true PL1613589T3 (pl) 2008-07-31

Family

ID=33103147

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07016889T PL1862455T3 (pl) 2003-04-01 2004-03-16 Kwas 11-((4R,6R)-4,5,6-trihydroksy-3-(R)-hydroksy-2-(S)-hydroksy-heksylokarbamoilo)-undekanowy
PL04720854T PL1613589T3 (pl) 2003-04-01 2004-03-16 Nowy difenyloazetydynon o polepszonych właściwościach fizjologicznych, sposób jego wytwarzania, środki lecznicze zawierające ten związek i jego zastosowanie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL07016889T PL1862455T3 (pl) 2003-04-01 2004-03-16 Kwas 11-((4R,6R)-4,5,6-trihydroksy-3-(R)-hydroksy-2-(S)-hydroksy-heksylokarbamoilo)-undekanowy

Country Status (43)

Country Link
US (2) US7205290B2 (pl)
EP (2) EP1613589B1 (pl)
JP (1) JP2006522040A (pl)
KR (1) KR20050119180A (pl)
CN (2) CN100361970C (pl)
AR (1) AR043783A1 (pl)
AT (2) ATE386020T1 (pl)
AU (1) AU2004226287B2 (pl)
BR (1) BRPI0408920A (pl)
CA (1) CA2520689A1 (pl)
CL (1) CL43489B (pl)
CR (1) CR7995A (pl)
CY (2) CY1107398T1 (pl)
DE (3) DE10314610A1 (pl)
DK (2) DK1613589T3 (pl)
EC (1) ECSP056071A (pl)
ES (2) ES2298731T3 (pl)
GT (1) GT200400058A (pl)
HN (1) HN2004000109A (pl)
HR (1) HRP20050870A2 (pl)
JO (1) JO2493B1 (pl)
MA (1) MA27753A1 (pl)
ME (1) MEP41408A (pl)
MX (1) MXPA05010128A (pl)
MY (1) MY136269A (pl)
NI (1) NI200500164A (pl)
NO (1) NO20055001L (pl)
NZ (1) NZ542751A (pl)
PA (1) PA8599401A1 (pl)
PE (1) PE20050011A1 (pl)
PL (2) PL1862455T3 (pl)
PT (2) PT1613589E (pl)
RS (1) RS51146B (pl)
RU (1) RU2334737C2 (pl)
SA (1) SA04250154B1 (pl)
SI (2) SI1862455T1 (pl)
SV (1) SV2004001756A (pl)
TN (1) TNSN05244A1 (pl)
TW (1) TW200504009A (pl)
UA (1) UA80754C2 (pl)
UY (1) UY28253A1 (pl)
WO (1) WO2004087655A1 (pl)
ZA (1) ZA200506708B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1345895B1 (de) * 2000-12-21 2006-12-27 Sanofi-Aventis Deutschland GmbH Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
TW200738676A (en) 2005-06-20 2007-10-16 Schering Corp Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
US7067689B1 (en) 2005-07-08 2006-06-27 Microbia, Inc. Process for production of pentahydroxyhexylcarbamoyl alkanoic acids
EP2061767B1 (de) 2006-08-08 2014-12-17 Sanofi Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung
US20080319218A1 (en) * 2007-06-22 2008-12-25 Andreas Haubrich Processes for Making and Using Benzyl Pentahydroxyhexylcarbamoylundecanoate
US20080319221A1 (en) * 2007-06-22 2008-12-25 Bernd Junker Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
DE102007029612A1 (de) * 2007-06-27 2009-01-08 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Pentahydroxyhexylcarbamoylundekan- säurebenzylester
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007054497B3 (de) * 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
WO2009100258A1 (en) * 2008-02-05 2009-08-13 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical solid state forms
WO2009112203A1 (de) * 2008-03-14 2009-09-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur herstellung eines diphenylazetidinons
DE102008059772A1 (de) 2008-12-01 2010-06-02 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung eines Diphenylazetidinons
DE102010015123A1 (de) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8895547B2 (en) 2011-03-08 2014-11-25 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120058A1 (de) 2011-03-08 2012-09-13 Sanofi Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120051A1 (de) 2011-03-08 2012-09-13 Sanofi Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683702B1 (de) 2011-03-08 2014-12-24 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US10426480B2 (en) * 2015-04-29 2019-10-01 Covidien Lp Cutting ring assembly with rigid cutting member

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US576470A (en) * 1897-02-02 Boiler-furnace
FR2663336B1 (fr) 1990-06-18 1992-09-04 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5756740A (en) * 1992-04-08 1998-05-26 Eastman Kodak Company Process for the preparation of binary sensitizing dyes
FR2713225B1 (fr) 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5633246A (en) * 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
EP0876379A1 (en) 1996-01-17 1998-11-11 Novo Nordisk A/S Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
IL128332A0 (en) 1996-08-30 2000-01-31 Novo Nordisk As GLP-1 derivatives
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
DE19726167B4 (de) * 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
RU2215004C2 (ru) 1997-07-16 2003-10-27 Ново Нордиск А/С Конденсированное производное 1,2,4-тиадиазина, фармацевтическая композиция и способ получения лекарственного препарата
CO4970713A1 (es) 1997-09-19 2000-11-07 Sanofi Synthelabo Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
HUP0101381A3 (en) 1998-03-12 2002-06-28 Microbial Chem Res Found Benzofurylpyrone derivatives and pharmaceutical compositions containing them
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19845405C2 (de) * 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung
CZ295044B6 (cs) 1998-12-07 2005-05-18 Societe De Conseils De Recherches Et D'application Analogy GLP-1, mající kyselinu aminoizomáselnou na pozicích 8 a 35, jejich použití a farmaceutické prostředky je obsahující
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
PL351470A1 (en) 1999-04-28 2003-04-22 Aventis Pharma Gmbh Tri-aryl acid derivatives as ppar receptor ligands
YU72201A (sh) 1999-04-28 2005-07-19 Aventis Pharma Deutschland Gmbh. Derivati di-aril kiseline kao ppar receptorski ligandi
GB9911863D0 (en) 1999-05-21 1999-07-21 Knoll Ag Therapeutic agents
US6399640B1 (en) 1999-06-18 2002-06-04 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
EP1204654B1 (en) 1999-07-29 2003-07-23 Eli Lilly And Company Benzofurylpiperazines: 5-ht2c serotonin receptor agonists
KR20020033778A (ko) * 1999-09-01 2002-05-07 로버트 흐라이탁, 미쉘 베스트 설포닐 카복스아미드 유도체, 이의 제조방법 및약제로서의 이의 용도
EP1259246A2 (en) 2000-02-25 2002-11-27 Novo Nordisk A/S Use of dpp-iv inhibitors for the treatment of diabetes
ATE369337T1 (de) 2000-04-28 2007-08-15 Asahi Kasei Pharma Corp Neue bizyklische verbindungen
ATE310728T1 (de) 2000-05-11 2005-12-15 Bristol Myers Squibb Co Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
SE0001899D0 (sv) 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds
HUP0004741A2 (hu) 2000-11-28 2002-12-28 Sanofi-Synthelabo Kémiai eljárás tiazolszármazékok előállítására és új intermedier
EP1345895B1 (de) * 2000-12-21 2006-12-27 Sanofi-Aventis Deutschland GmbH Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
DE10139416A1 (de) 2001-08-17 2003-03-06 Aventis Pharma Gmbh Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6884812B2 (en) * 2001-08-31 2005-04-26 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
AU2002333456B2 (en) * 2001-08-31 2008-07-17 Sanofi-Aventis Deutschland Gmbh Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as PPAR activators
US7176194B2 (en) * 2002-06-19 2007-02-13 Sanofi-Aventis Deutschland Gmbh Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
GB0215579D0 (en) * 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
SI1862455T1 (sl) 2009-06-30
PT1862455E (pt) 2009-04-23
CY1109055T1 (el) 2014-07-02
TW200504009A (en) 2005-02-01
PA8599401A1 (es) 2004-10-08
ZA200506708B (en) 2007-01-31
TNSN05244A1 (en) 2007-06-11
AU2004226287A1 (en) 2004-10-14
US7772429B2 (en) 2010-08-10
GT200400058A (es) 2004-11-10
JP2006522040A (ja) 2006-09-28
EP1613589B1 (de) 2008-02-13
KR20050119180A (ko) 2005-12-20
AU2004226287B2 (en) 2010-03-18
MXPA05010128A (es) 2005-11-16
CN101139306A (zh) 2008-03-12
SA04250154B1 (ar) 2007-10-29
ES2298731T3 (es) 2008-05-16
PL1862455T3 (pl) 2009-07-31
CN1768034A (zh) 2006-05-03
WO2004087655A1 (de) 2004-10-14
RU2005133631A (ru) 2006-03-10
DK1862455T3 (da) 2009-06-02
US20050020563A1 (en) 2005-01-27
US7205290B2 (en) 2007-04-17
PT1613589E (pt) 2008-03-27
BRPI0408920A (pt) 2006-03-28
NI200500164A (es) 2006-01-11
DK1613589T3 (da) 2008-06-09
RS20050719A (sr) 2008-04-04
MA27753A1 (fr) 2006-02-01
EP1862455B1 (de) 2009-02-25
EP1862455A3 (de) 2007-12-12
ATE386020T1 (de) 2008-03-15
RS51146B (sr) 2010-10-31
DE502004006195D1 (de) 2008-03-27
CA2520689A1 (en) 2004-10-14
HRP20050870A2 (en) 2006-10-31
CL43489B (es) 2005-01-21
PE20050011A1 (es) 2005-02-28
SV2004001756A (es) 2004-11-18
SI1613589T1 (sl) 2008-06-30
NZ542751A (en) 2007-05-31
DE502004009059D1 (de) 2009-04-09
MEP41408A (en) 2011-02-10
UA80754C2 (en) 2007-10-25
ATE423766T1 (de) 2009-03-15
JO2493B1 (en) 2009-10-05
MY136269A (en) 2008-09-30
RU2334737C2 (ru) 2008-09-27
HK1087697A1 (zh) 2006-10-20
US20070197498A1 (en) 2007-08-23
ECSP056071A (es) 2006-01-27
EP1862455A2 (de) 2007-12-05
HN2004000109A (es) 2008-02-21
EP1613589A1 (de) 2006-01-11
CN100361970C (zh) 2008-01-16
CY1107398T1 (el) 2012-12-19
CR7995A (es) 2006-09-22
ES2322876T3 (es) 2009-06-30
UY28253A1 (es) 2004-11-08
NO20055001L (no) 2005-10-27
DE10314610A1 (de) 2004-11-04
AR043783A1 (es) 2005-08-10

Similar Documents

Publication Publication Date Title
PT1613589E (pt) Nova difenilazetidinona com características fisiológicas melhoradas, processo para a sua preparação, medicamentos contendo este composto e sua utilização
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
PL375344A1 (pl) Nowe związki karboksyamidowe działające antagonistycznie wobec MCH, środki medyczne zawierające te związki oraz sposoby ich wytwarzania
AU2003270262A1 (en) Novel beta mimetics with extended duration of action, method for production and use thereof as medicaments
AU2003292239A8 (en) Novel carboxamides, the production and use thereof as medicaments
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
HRP20041203A2 (en) Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
AU2003257465A1 (en) Substituted diaryl heterocycles, method for the production and use thereof as medicaments
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
PL373329A1 (pl) Heterocyklicznie podstawione benzoilomoczniki, sposób ich wytwarzania oraz zastosowanie ich jako środka leczniczego
HRP20030501A2 (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
PL364097A1 (pl) Kompozycja polisiloksanu, sposób jej otrzymywaniai kształtowany produkt
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
PL376399A1 (pl) Nowe związki pirydopirymidynowe, proces ich wytwarzania i zawierające je mieszanki farmaceutyczne
ZA200506422B (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
IL175245A0 (en) Thiozolidinones, production and use thereof as medicaments
PL371784A1 (pl) Pentafluorotio-benzoiloguanidyny, sposób ich wytwarzania, ich zastosowanie jako środka leczniczego lub diagnostycznego oraz środek leczniczy zawierający te związki
PT1638943E (pt) Novos derivados de imidazoles, sua preparação e sua utilização como medicamento
PL372589A1 (pl) Podstawione tiofeny, sposób ich otrzymywania, ichzastosowanie jako leku lub środka diagnostycznegooraz leki zawierające te związki
MXPA03006648A (es) Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos.
IS8491A (is) Nýtt efnasamband, samsvarandi blöndur, framleiðslu- og/eða meðhöndlunaraðferðir
AU2003294952A8 (en) 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same
IL173918A0 (en) Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
IL162562A0 (en) Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid
AU2003235132A1 (en) Honey, novel honey composition and process for producing the same